Clinical Trials on Infant, Newborn, Diseases in New Zealand

Total 43908 results

BLIS Technologies Limited

Recruiting

Colonisation Efficacy of Oral Probiotic Fast Melt Powder

Microbial Colonization

New Zealand
Drugs for Neglected Diseases
Universiteit Antwerpen; PENTA Foundation; St George's, University of London

Completed

NeoAMR Observational Study in Neonatal Sepsis

Neonatal SEPSIS

Bangladesh, Uganda, Thailand, South Africa, Italy, Greece, India, Brazil, China, Kenya, Vietnam
Proteostasis Therapeutics, Inc.

Completed

Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis

Healthy Volunteer - Complete | Cystic Fibrosis - Complete

United States, Belgium, United Kingdom, France, Germany, Canada, Denmark, New Zealand, Australia
Parion Sciences
Vertex Pharmaceuticals Incorporated

Completed

Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF) (CLEAN-CF)

Cystic Fibrosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study) (EDEN-Omega)

Respiratory Distress Syndrome, Adult

United States
Azitra Inc.

Not yet recruiting

Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome

Netherton Syndrome

United States
Dartmouth-Hitchcock Medical Center

Recruiting

Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome

Cystic Fibrosis

United States
My Music Machines Inc.
National Heart, Lung, and Blood Institute (NHLBI); Albany Medical College

Withdrawn

The Effectiveness of the Jamboxx Respiratory Therapy Device: Study 2

Cystic Fibrosis in Children

United States
BLIS Technologies Limited

Recruiting

Microbial Colonization of Oral Probiotics

Microbial Colonization

New Zealand
BLIS Technologies Limited

Active, not recruiting

Colonization of Skin by M. Luteus Q24 Probiotic

Microbial Colonization

New Zealand
BLIS Technologies Limited

Not yet recruiting

Colonisation of Scalp by Topical Probiotic Micrococcus Luteus Q24

Microbial Colonization

New Zealand
BLIS Technologies Limited

Not yet recruiting

Probiotic Toothpaste to Assess Microbial Colonization

Microbial Colonization

New Zealand
John Hale

Recruiting

Probiotic Toothpaste for Microbial Colonization

Microbial Colonization

New Zealand
John Hale

Recruiting

Microbial Colonization of Dairy Free Oral Probiotics

Microbial Colonization

New Zealand
Northwell Health
New York State Department of Health

Recruiting

Continuous Vital Sign Monitoring in Newborns

Newborn Complication

United States
Vertex Pharmaceuticals Incorporated

Completed

A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis

Cystic Fibrosis

United States, United Kingdom
Mallinckrodt

Completed

Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants

Bronchopulmonary Dysplasia

United States, Canada
Weill Medical College of Cornell University

Completed

Delayed Cord Clamping in Preterm Neonates (DCC)

Premature Birth of Newborn | Infant, Very Low Birth Weight | Placental Transfusion | Delayed Separation of Umbilical Cord

United States
InfaCare Pharmaceuticals Corporation, a Mallinckrodt...

Completed

Stannsoporfin With Light Therapy for Newborn Babies With Jaundice (JASMINE_204)

Hyperbilirubinemia, Neonatal | Jaundice, Neonatal

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET)

Critical Illness | Vitamin D Deficiency | Acute Respiratory Distress Syndrome

United States
Vertex Pharmaceuticals Incorporated

Terminated

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

Cystic Fibrosis

United States, Canada
Route 92 Medical, Inc.

Completed

Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMITNZ)

Acute Ischemic Stroke

New Zealand
Stryker South Pacific

Not yet recruiting

A Trial of Mechanical Axis With Soft Tissue Release Balancing vs Functional Alignment With Bony Release Balancing in Total Knee Replacement Using Stryker's Mako Robot

Osteoarthritis

New Zealand
Timber Pharmceuticals LLC

Completed

A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis

Congenital Ichthyosis

United States, Australia
Christchurch Clinical Studies Trust Ltd
Medtronic

Unknown

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

Type1diabetes

New Zealand
Spero Therapeutics
United States Department of Defense

Completed

Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Renal Impairment

New Zealand
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); Laval University

Active, not recruiting

Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia (MOBYDIck)

Child Development | Bronchopulmonary Dysplasia | Neonatal and Perinatal Conditions

Canada
Eunice Kennedy Shriver National Institute of Child...
Rockefeller University

Completed

Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

Hyperbilirubinemia | Glucosephosphate Dehydrogenase Deficiency | Hemolytic Disease of Newborn

United States
GlaxoSmithKline

Completed

A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.

Asthma

New Zealand
Gilead Sciences

Completed

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection (LEPTON)

Chronic Hepatitis C

New Zealand
Alvotech Swiss AG

Completed

AVT03 With Prolia in Healthy Male Subjects

Healthy Male Subjects

New Zealand
GlaxoSmithKline

Completed

Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate

Asthma

New Zealand
InterMune

Completed

Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

Cystic Fibrosis

United States
Arrowhead Pharmaceuticals

Completed

Study of ARO-AAT in Normal Adult Volunteers

Alpha 1-Antitrypsin Deficiency

New Zealand
Bridge Biotherapeutics, Inc.
Covance

Terminated

Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Ulcerative Colitis

New Zealand
Christchurch Hospital

Unknown

How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

Diabetes Mellitus, Type 2

New Zealand
GE Healthcare

Completed

Evaluation of Orthopedic Knee Measurement Using Lunar iDXA

Hemi Knee Arthroplasty | Patello-femoral Osteoarthritis

New Zealand
Vertex Pharmaceuticals Incorporated

Completed

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

Hepatitis C | Chronic Hepatitis C | HCV | CHC

New Zealand
Fisher and Paykel Healthcare

Recruiting

Oxygen Wound Therapy Feasibility Study

Chronic Leg Ulcer

New Zealand
Northwestern University
Icahn School of Medicine at Mount Sinai; Galderma R&D

Recruiting

Defining the Skin and Blood Biomarkers of Ichthyosis

Netherton Syndrome | Ichthyosis

United States
Massachusetts General Hospital

Completed

Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery (ASTER)

Sepsis | Critical Illness | Respiratory Failure | Acute Respiratory Distress Syndrome

United States
Ward Photonics LLC

Terminated

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

COVID-19 | Acute Respiratory Distress Syndrome

United States
Edgar National Centre for Diabetes Research

Completed

He Purongo Mo Nga Kai Hei Arai i Te Matehuka - Dietary Diabetes Prevention Study for Maori

Insulin Resistance

New Zealand
Shape Memory Medical, Inc.

Active, not recruiting

Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks (AAA-SHAPE)

Abdominal Aortic Aneurysm

New Zealand
University of Auckland, New Zealand

Completed

Gastrografin in Postoperative Ileus (GAP)

Prolonged Postoperative Ileus

New Zealand
Innate Immunotherapeutics
National Multiple Sclerosis Society; Primorus Clinical Trials

Completed

Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

New Zealand
George Solomon
Cystic Fibrosis Foundation

Recruiting

Rare CFTR Mutation Cell Collection Protocol (RARE) (RARE)

Cystic Fibrosis

United States
Pfenex, Inc

Completed

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Age Related Macular Degeneration (AMD)

New Zealand
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)

Cystic Fibrosis

United States, Spain, United Kingdom, New Zealand, Israel, Australia, Ireland, Germany, Sweden, Czechia, Portugal, Hungary
Waikato Hospital

Enrolling by invitation

A Comparison of Metacarpophalangeal Joint Blocking Splint With Relative Motion Extension Splint for Trigger Finger

Trigger Finger

New Zealand

Clinical Trials on Infant, Newborn, Diseases in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations